Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 3/20 | 0.55 |
| ▸ | HSD11B2 | P80365 | 1/20 | 0.55 |
| ▸ | SELP | P16109 | 1/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 2/20 | 0.38 |
| ▸ | BCHE | P06276 | 1/20 | 0.38 |
| ▸ | XDH | P47989 | 2/20 | 0.38 |
| ▸ | SYNJ2 | O15056 | 1/20 | 0.35 |
| ▸ | F3 | P13726 | 3/20 | 0.34 |
| ▸ | TOP1 | P11387 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19755907 | 0.97 | HSD11B1 (0.51) | HSD11B1HSD11B2SELPPTPN1ACHE | |
| SCHEMBL26711280 | 0.96 | HSD11B1 (0.51) | HSD11B1HSD11B2SELPPTPN1ACHE | |
| SCHEMBL24961911 | 0.92 | HSD11B1 (0.46) | HSD11B1HSD11B2SELPPTPN1ACHE | |
| SCHEMBL17982560 | 0.85 | PTPN1 (0.53) | HSD11B1HSD11B2SELPPTPN1F3 | |
| SCHEMBL21202083 | 0.85 | PTPN1 (0.53) | HSD11B1HSD11B2SELPPTPN1F3 | |
| SCHEMBL16048075 | 0.85 | PTPN1 (0.53) | HSD11B1HSD11B2SELPPTPN1F3 | |
| SCHEMBL18979864 | 0.85 | PTPN1 (0.53) | HSD11B1HSD11B2SELPPTPN1F3 | |
| SCHEMBL23541386 | 0.83 | SYNJ2 (0.41) | HSD11B1HSD11B2SELPACHEXDH | |
| SCHEMBL19755906 | 0.83 | PTPN1 (0.50) | HSD11B1HSD11B2SELPPTPN1F3 | |
| SCHEMBL24961200 | 0.82 | SELP (0.49) | HSD11B1HSD11B2SELPPTPN1F3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10364450-B2 | Production of steviol glycoside in recombinant hosts | EVOLVA SA (CH) | 2019-07-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10364450-B2 | Production of steviol glycoside in recombinant hosts | ERG28, KISS1R, STT3A | HSD11B1 160/4885HSD11B2 149/4885SELP 1162/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.